Onconetix, Inc. cotiza a 0.56 USD y tiene una capitalización bursátil de $3M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a l…
| Periodo | 2023-11 | 2023-10 | 2023-05 | 2023-03 |
|---|---|---|---|---|
| Real | $-52700.03 | $-73100.04 | $-30600.02 | $-27200.01 |
| Estimado | $-32300.02 | $-30600.02 | $-34850.02 | $-45050.02 |
| Sorpresa | -63.2% | -138.9% | +12.2% | +39.6% |
| Métrica | ONCO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 77.6% | 57.0% | +20.6% |
| Operating Margin | -2190.0% | -38.6% | -2151.4% |
| Net Margin | -1721.0% | -33.6% | -1687.4% |
| FCF Margin | — | -13.9% | — |
| ROE | -89.0% | -40.4% | -48.6% |
| ROA | -56.3% | -32.0% | -24.3% |
| Current Ratio | 0.66 | 2.84 | -2.18 |
| Debt / Equity | — | 0.28 | — |